Albemarle CORP Form 4 insider transactions

NYSE
Albemarle Corporation's Chairman and CEO, J Kent Masters, reported the vesting of performance stock units and subsequent tax-related share withholding.
NYSE
Albemarle Corp. Director Michelle T. Collins was granted 325 shares of common stock as part of her non-employee director compensation plan, vesting July 1, 2026.
NYSE
Albemarle's General Counsel, Ander C. Krupa, reported the sale of 188 shares of common stock to cover tax liabilities related to vested Restricted Stock Units.
NYSE
Albemarle's Chief People Officer, Autumn M. Gagarinas, disposed of 566 shares of common stock to cover tax liabilities from RSU vesting.
NYSE
Albemarle's SVP of External Affairs and Communications, Cynthia R. Lima, reported the withholding of 340 shares of common stock to cover tax liabilities related to RSU vesting.
NYSE
Albemarle Corporation's Chief Business Transformation Officer, Melissa H. Anderson, reported the withholding of 565 common shares to cover tax liabilities from vested Restricted Stock Units.
NYSE
Albemarle's VP, Corporate Controller & CAO, Donald J. LaBauve Jr., disposed of 164 shares of common stock to cover tax liabilities related to vested restricted stock units.
NYSE
Albemarle's Chief Commercial Officer, Eric Norris, disposed of 887 shares of common stock to cover tax liabilities related to RSU vesting.
NYSE
Albemarle's Chief Supply Chain Officer, Mark Richard Mummert, disposed of 375 shares of common stock to cover tax liabilities related to RSU vesting.
NYSE
Albemarle Corporation's Chief Commercial Officer, Eric Norris, reported the sale of 5,692 shares of common stock at $165.45 per share, executed under a pre-arranged 10b5-1 trading plan.
NYSE
Albemarle Chairman and CEO J. Kent Masters reported the disposition of common stock to cover tax liabilities from RSU vesting.
NYSE
Albemarle's Chief Financial Officer, Neal Ravi Sheorey, reported the vesting of Restricted Stock Units and subsequent share withholding for tax obligations.
NYSE
Albemarle's General Counsel and Secretary, Ander C. Krupa, reported the sale of 172 shares of common stock at $105 per share.
NYSE
Albemarle's General Counsel, Ander C. Krupa, sold 116 shares of common stock for $95 per share on October 9, 2025, as part of a pre-arranged 10b5-1 trading plan.
NYSE
Albemarle Corporation's General Counsel, Ander C. Krupa, was granted 7,430 Restricted Stock Units vesting in 2028.
NYSE
Albemarle Corporation Director Diarmuid B. O'Connell reported the acquisition of 2,725 shares as annual stock compensation and an additional 37 shares from accrued dividends, increasing his direct beneficial ownership to 8,233 shares.
NYSE
Albemarle Corporation Director Laurie Brlas reported the acquisition of 2,725 shares as annual non-employee director stock compensation and an additional 37 shares from accrued dividends, increasing her direct beneficial ownership to 6,003 shares.
NYSE
Albemarle Corporation's Director, James J. O'Brien, acquired 2,762 shares of common stock through annual compensation and dividend reinvestment, increasing his direct beneficial ownership to 8,085 shares.
NYSE
Albemarle Corporation Director Gerald A. Steiner reported the acquisition of 2,762 shares of common stock through director compensation and dividend reinvestment, increasing his direct beneficial ownership to 11,012 shares.
NYSE
Albemarle Corporation Director Ralf Cramer reported the acquisition of 2,762 shares of common stock as compensation and dividends, alongside the disposition of 615 shares for tax liabilities, resulting in a beneficial ownership of 5,379 shares.
NYSE
Albemarle Corporation Director Alejandro Daniel Wolff acquired additional common stock and phantom stock units as part of the company's non-employee director compensation plan.
NYSE
Albemarle Corporation Director Dean Seavers acquired 2,762 shares of common stock on July 1, 2025, through annual director compensation and dividend reinvestment, increasing his direct beneficial ownership to 12,021 shares.
NYSE
Albemarle Corporation's Director, Holly Van Deursen, was granted 2,725 phantom stock units as part of her annual non-employee director compensation, vesting on July 1, 2026.
NYSE
Albemarle Corporation Director Glenda J. Minor acquired additional common stock and phantom stock units as part of her compensation plan, increasing her beneficial ownership in the company.
NYSE
Donald J. LaBauve Jr., VP, Corporate Controller & CAO of Albemarle Corp, reports acquisition of shares and stock options.
NYSE
Melissa H. Anderson, Chief People Officer at Albemarle Corp, reports acquisition of stock and options, and disposal of stock.
NYSE
SVP of External Affairs & Communications at Albemarle Corp, Cynthia Renee Lima, reports acquisition of common stock and stock options.
NYSE
Mark Richard Mummert, Chief Supply Chain Officer of Albemarle Corp, reports acquisition of common stock and stock options.
NYSE
General Counsel & Secretary of Albemarle Corp, Grant Stacy Goto, reports acquisition of stock and stock options.
NYSE
Chief Commercial Officer Eric Norris of Albemarle Corporation reports acquiring and disposing of common stock and acquiring stock options on February 27, 2025.